Right heart catheterization(RHC) plays a crucial role in the diagnosis and treatment of pulmonary vascular diseases(PVD). In China, the lack of equipment and technical expertise has historically limited the implementation of RHC, thereby greatly restricting the diagnosis and treatment of RVD. In recent years, with improvements in these issues, more hospitals have acquired the capability to perform RHC. The purpose of this study is to conduct quality control of RHC across multiple pulmonary hypertension(PH) centers in China. The study population consists of patients who underwent RHC for the first time due to dyspnea or suspected PH. This study retrospectively and prospectively collects multicenter RHC data, with the main quality control contents including indications for the procedure, collection and analysis of hemodynamic data, diagnosis and treatment, and long-term management of patients.
Patients who underwent right heart catheterization for the first time due to dyspnea or suspected pulmonary hypertension
Age ≥14 years old
Vital data missing
Did not sign informed consent or did not agree to follow-up
Patients who underwent right heart catheterization for the first time due to dyspnea or suspected pulmonary hypertension and age over 14 years old
Cohort
Prospective
No intervention; Observational study
Other interventionNo intervention; observational study
3-month all cause death
3-month all cause death
dignosis and type of pulmonary hypertension
dignosis and type of pulmonary hypertension according to latest guidelines
1-year all cause death
1-year all cause death
Click on the lead sponsor to view all of their trials.
